Torthaí cuardaigh - Pieters, Rob

HOXA-activated early T-cell progenitor acute lymphoblastic leukemia: predictor of poor outcome? de réir Meijerink, Jules PP., Canté-Barrett, Kirsten, Vroegindeweij, Eric, Pieters, Rob

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Pyruvate kinase M2 and prednisolone resistance in acute lymphoblastic leukemia de réir Hulleman, Esther, Broekhuis, Mathilde JC, Pieters, Rob, Den Boer, Monique L

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia de réir Mendes, Rui D., Canté-Barrett, Kirsten, Pieters, Rob, Meijerink, Jules P.P.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model de réir Kloos, Robin Q.H., Mathôt, Ron, Pieters, Rob, van der Sluis, Inge M.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Desensitization protocol should not be used in acute lymphoblastic leukemia patients with silent inactivation of PEGasparaginase de réir Tong, Wing H., Pieters, Rob, Tissing, Wim J.E., van der Sluis, Inge M.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Cytotoxic Effects of Vitamin A in Combination with Vincristine, Daunorubicin and 6‐Thioguanine upon Cells from Lymphoblastic Leukemic Patients de réir Pieters, Rob, Huismans, Dieuwke R., Loonen, Anne H., Hählen, Karel, Veerman, Anjo J. P.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia de réir Buitenkamp, Trudy D., Mathôt, Ron A.A., de Haas, Valerie, Pieters, Rob, Zwaan, C. Michel

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective de réir de Bont, Judith M., Packer, Roger J., Michiels, Erna M., den Boer, Monique L., Pieters, Rob

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Trametinib inhibits RAS-mutant MLL-rearranged acute lymphoblastic leukemia at specific niche sites and reduces ERK phosphorylation in vivo de réir Kerstjens, Mark, Pinhancos, Sandra S., Castro, Patricia Garrido, Schneider, Pauline, Wander, Priscilla, Pieters, Rob, Stam, Ronald W.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Irinotecan Induces Disease Remission in Xenograft Mouse Models of Pediatric MLL-Rearranged Acute Lymphoblastic Leukemia de réir Kerstjens, Mark, Garrido Castro, Patricia, Pinhanços, Sandra S., Schneider, Pauline, Wander, Priscilla, Pieters, Rob, Stam, Ronald W.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements de réir Homminga, Irene, Vuerhard, Maartje J., Langerak, Anton W., Buijs-Gladdines, Jessica, Pieters, Rob, Meijerink, Jules P.P.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations de réir Kerstjens, Mark, Driessen, Emma M.C., Willekes, Merel, Pinhanços, Sandra S., Schneider, Pauline, Pieters, Rob, Stam, Ronald W.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies de réir Cordo', Valentina, van der Zwet, Jordy C.G., Canté-Barrett, Kirsten, Pieters, Rob, Meijerink, Jules P.P.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Effect of Treatment in a Specialized Pediatric Hemato-Oncology Setting on 5-Year Survival in Acute Lymphoblastic Leukemia: A Quasi-Experimental Study de réir van der Linde, Margrietha, van Leeuwen, Nikki, Eijkenaar, Frank, Rijneveld, Anita W., Pieters, Rob, Karim-Kos, Henrike E.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

MLL fusion-driven activation of CDK6 potentiates proliferation in MLL-rearranged infant ALL de réir van der Linden, Marieke H, Willekes, Merel, van Roon, Eddy, Seslija, Lidija, Schneider, Pauline, Pieters, Rob, Stam, Ronald W

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Acute lymphoblastic leukemia cells create a leukemic niche without affecting the CXCR4/CXCL12 axis de réir de Rooij, Bob, Polak, Roel, van den Berk, Lieke C.J., Stalpers, Femke, Pieters, Rob, den Boer, Monique L.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

High PDGFRA expression does not serve as an effective therapeutic target in ERG-deleted B-cell precursor acute lymphoblastic leukemia de réir Jerchel, Isabel S., Chatzivasileiou, Danai, Hoogkamer, Alex Q., Boer, Judith M., Beverloo, H. Berna, Pieters, Rob, den Boer, Monique L.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Recent perspectives on the association between osteonecrosis and bone mineral density decline in childhood acute lymphoblastic leukemia de réir van Atteveld, Jenneke E, de Winter, Demi TC, Pieters, Rob, Neggers, Sebastian JCMM, van den Heuvel-Eibrink, Marry M

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase de réir Pieters, Rob, Hunger, Stephen P, Boos, Joachim, Rizzari, Carmelo, Silverman, Lewis, Baruchel, Andre, Goekbuget, Nicola, Schrappe, Martin, Pui, Ching-Hon

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Alterations in Epithelial and Mesenchymal Intestinal Gene Expression During Doxorubicin-Induced Mucositis in Mice de réir de Koning, Barbara A E, Lindenbergh-Kortleve, Dicky J., Pieters, Rob, Büller, Hans A., Renes, Ingrid B., Einerhand, Alexandra W. C.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán